At the 21st World Congress of Endoscopic Surgery (WCES 2025) in Singapore, Miconvey presented a comprehensive showcase of its innovations in minimally invasive surgery, standing out as one of the event’s Silver Sponsors. Held at the Suntec Singapore Convention & Exhibition Centre, the congress gathered more than 1,500 surgeons, educators, and industry leaders for four(4) days of scientific exchange focused on the future of endo-laparoscopic surgery. Against this vibrant backdrop of cutting-edge research, masterclasses, and technology demonstrations, Miconvey offered an immersive experience into its expanding portfolio of stapling and ultrasonic systems.
Throughout the congress, visitors to Miconvey’s booth experienced a full spectrum of MIS tools engineered to deliver reliability, precision, and consistency in high-acuity surgical environments. The QELC™ Endoscopic Linear Cutting Stapler drew considerable attention for its refined mechanical intelligence, incorporating guiding-staple architecture and a stable anti-slip chain mechanism designed to deliver uniform compression and dependable B-shaped staple formation across variable anatomies. Surgeons also engaged closely with the QOLC™ Endoscopic Linear Cutter, a device built around reinforced beam engineering and guided-closure geometry to ensure stable anastomosis and secure tissue management in complex laparoscopic procedures.
Interest was equally strong in Miconvey’s powered platforms. The Adeptis™ Powered Stapler, known for its Triple Sensations feedback and dual-replacements configuration, demonstrated how thoughtful mechanical innovation can enhance firing confidence without increasing operational complexity. Meanwhile, the Avian™ Powered Stapler was recognized for its ergonomic responsiveness and balanced firing performance, positioning it as a dependable tool for surgeons navigating demanding MIS pathways. Complementing the stapling systems, the AutoForce™ K600 Ultrasonic Surgical System showcased its capabilities in delivering precise dissection and effective hemostasis through its combination of Tissue Reactive Technology and adaptive energy delivery, resulting in controlled performance with reduced thermal effect.
Beyond product demonstrations, WCES provided a fertile environment for deep clinical dialogue. Surgeons and hospital leaders from Asia-Pacific, the Middle East, and Europe exchanged insights on tissue behavior, device feel, workflow integration, and the evolving needs of modern operating rooms. Many expressed appreciation for Miconvey’s philosophy of developing technology that enhances surgical safety without introducing unnecessary complexity which is an approach that resonated strongly during scientific sessions discussing innovation in tissue approximation, value-driven outcomes in MIS, robotics, artificial intelligence in surgery, and the operating room of the future.
The congress reaffirmed a central truth: meaningful progress in MIS comes from innovations that are intuitive, dependable, and aligned with real surgical challenges. For Miconvey, this mission remains anchored in its guiding vision, “All Efforts For Health,” a philosophy that continues to shape every aspect of the company’s engineering and clinical collaborations. As WCES 2025 concluded, Miconvey’s commitment was clearer than ever. The future of surgery will be shaped by collective learning, multidisciplinary insight, and partnerships grounded in shared purpose and Miconvey is proud to stand alongside the global surgical community as these advancements unfold.
